Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4WNP

Structure of ULK1 bound to a potent inhibitor

4WNP の概要
エントリーDOI10.2210/pdb4wnp/pdb
関連するPDBエントリー4WNO
分子名称Serine/threonine-protein kinase ULK1, GLYCEROL, N~2~-(1H-benzimidazol-6-yl)-N~4~-(5-cyclobutyl-1H-pyrazol-3-yl)quinazoline-2,4-diamine, ... (4 entities in total)
機能のキーワードkinase, autophagy, inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (Human)
細胞内の位置Cytoplasm, cytosol : O75385
タンパク質・核酸の鎖数4
化学式量合計131051.03
構造登録者
Lazarus, M.B.,Novotny, C.J.,Shokat, K.M. (登録日: 2014-10-14, 公開日: 2015-01-14, 最終更新日: 2024-11-13)
主引用文献Lazarus, M.B.,Novotny, C.J.,Shokat, K.M.
Structure of the Human Autophagy Initiating Kinase ULK1 in Complex with Potent Inhibitors.
Acs Chem.Biol., 10:257-261, 2015
Cited by
PubMed Abstract: Autophagy is a conserved cellular process that involves the degradation of cellular components for energy maintenance and cytoplasmic quality control that has recently gained interest as a novel target for a variety of human diseases, including cancer. A prime candidate to determine the potential therapeutic benefit of targeting autophagy is the kinase ULK1, whose activation initiates autophagy. Here, we report the first structures of ULK1, in complex with multiple potent inhibitors. These structures show features unique to the enzyme and will provide a path for the rational design of selective compounds as cellular probes and potential therapeutics.
PubMed: 25551253
DOI: 10.1021/cb500835z
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.88 Å)
構造検証レポート
Validation report summary of 4wnp
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon